Impax Laboratories (IPXL) Tops Q1 EPS by 4c

May 10, 2016 6:43 AM EDT

Impax Laboratories (NASDAQ: IPXL) reported Q1 EPS of $0.43, $0.04 better than the analyst estimate of $0.39. Revenue for the quarter came in at $226 million versus the consensus estimate of $247.2 million.

Impax Laboratories reaffirmed FY2016 guidance.

For earnings history and earnings-related data on Impax Laboratories (IPXL) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings